Legal challenge over thalidomide compensation certified as class action
TORONTO — A legal challenge against the Canadian government by alleged thalidomide survivors can proceed as a class action, the Federal Court of Appeal ruled on Thursday.
In addition to certifying the class action, the Appeal Court also appointed Bruce Wenham as representative plaintiff.
“Owing to legal errors, the order of the Federal Court cannot stand,” the Federal Court of Appeal said in overturning an earlier ruling that denied certification.
Developed by the German pharmaceutical company Chemie Grunenthal, thalidomide is still considered one of the worst failures of drug research. The government-approved anti-nausea and sleep drug was widely prescribed to pregnant women in the 1950s and 1960s. However, it turned out to cause severe fetal defects.


